Mystic Asset Management, Inc. Supernus Pharmaceuticals, Inc. Put Options Transaction History
Mystic Asset Management, Inc.
- $437 Million
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
324Shares Held
61MCall Options Held
18.4KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$491 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$286 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.81MShares$227 Million2.66% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$143 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.76MShares$131 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.53B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...